Despina Televantou - Concepedia

Author

Despina Televantou

Papageorgiou General Hospital

Also Known As

D Televantou, D. Televantou, D., Televantou, DESPINA TELEVANTOU, Despina Televantou, Despina Televantou (161062)

Publications

Citations

H-Index

Concepts

All Affiliations

Papageorgiou General Hospital Aristotle University of Thessaloniki Newcastle University Metropolitan Hospital Hippocration General Hospital

About

Despina Televantou is an author at Papageorgiou General Hospital specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	269
2	Cell Biology	2	2	83
3	Health Sciences	1	1	24
4	Natural Sciences	1	1	51
5	Biochemistry	1	1	51

Despina Televantou

Publications

995

Citations

H-Index

Page 1

	Year	Citations
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma Richard A. Noble, Natalie Bell, Helen J. Blair, Haematologica	2017	138
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes George Pentheroudakis, Vassiliki Kotoula, Wendy De Roock, BMC Cancer	2013	111
Volumetric and MGMT parameters in glioblastoma patients: Survival analysis Georgios Iliadis, Vassiliki Kotoula, Athanasios Chatzisotiriou, BMC Cancer	2012	91
DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival Liam Cornell, Joanne M. Munck, Clara Alsinet, Clinical Cancer Research	2014	85
Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression Evangelia Razis, Konstantine T. Kalogeras, Vassiliki Kotoula, Clinical Breast Cancer Breast OncologyMedicinePathologyBreast CancerCancer Genetics	2012	57
Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel George Fountzilas, Urania Dafni, Mattheos Bobos, PLoS ONE	2012	55
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis Lars P. Bechmann, Diana Vetter, Junichi Ishida, Journal of Hepatology HepatologyBiochemistryMedicineLiver PhysiologyNatural Sciences	2013	51
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma Alexander M. Newman, Masood Zaka, Peixun Zhou, Leukemia	2021	45
Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship L. Jeffrey Medeiros, Mario L. Marques‐Piubelli, Valentina Sangiorgio, Modern Pathology Lymphoid NeoplasiaImmunologyPathologyBreast CancerBreast Surgery	2021	40
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials George Fountzilas, Urania Dafni, Mattheos Bobos, BMC Cancer	2013	33

Page 1